Europe's EMEA recommends to refuse Leqembi, Eisai's "anti-Alzheimer's" antibody. It's approved by the FDA in the US. I think the EMEA is making the right call. The clinical data and modest improvements (if any) are really not convincing imo.

https://www.ema.europa.eu/en/medicines/human/EPAR/leqembi

#science

#neuroscience